CysBio ApS: Financial statements 2021
CVR: 40270752
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
CysBio ApS (CVR 40270752) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -6,310,970 and a net result of DKK -13,678,022 compared with DKK -20,510 the year before. Equity in the 2021 report amounted to DKK 22,015,919. The solvency ratio was 90.8%. The company had 4 employees in the financial year.
- Gross Profit
- DKK -6,310,970
- Profit/Loss
- DKK -13,678,022
- Equity
- DKK 22,015,919
- Total Assets
- DKK 24,239,239
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -6.3 mio. | -13.7 mio. | 22 mio. | 4 |
| 2020 | - | 8 mio. | -21 t. | 35.7 mio. | 4 |
| 2019 | - | -2.1 mio. | -5.2 mio. | 17.2 mio. | - |
Official annual report
Find more companies like CysBio ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
CysBio ApS has published its annual report for 2020. Gross profit came to DKK 8,047,449, and the net result was DKK -20,510.
About CysBio ApS
CysBio ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Alex Toftgaard Nielsen. The board consists of Alex Toftgaard Nielsen (chair), Christian Bille Jendresen and Xu Chaofeng. The company's owners include Danmarks Tekniske Universitet, Hemanshu Share Holding ApS and Christian Bille Jendresen Holding ApS. According to the 2025 annual report, the company had an average of 13 employees. In 2025, the company reported a gross profit of DKK 9,930,247 and a net result of DKK 124,708 compared with DKK -12,602,635 the year before. Equity in the 2025 report amounted to DKK -8,792,805.